Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v17-EN Version v9-EN
Language English English
Date Updated 2019-07-13 2019-05-01
Drug Identification Number 02299615 02299615
Brand name APO-DORZO-TIMOP APO-DORZO-TIMOP
Common or Proper name DORZOLAMIDE-TIMOLOL DORZOLAMIDE-TIMOLOL
Company Name APOTEX INC APOTEX INC
Ingredients TIMOLOL DORZOLAMIDE TIMOLOL DORZOLAMIDE
Strength(s) 5MG 20MG 5MG 20MG
Dosage form(s) SOLUTION SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 10 mL 10 mL
ATC code S01ED S01ED
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2015-10-06 2015-10-06
Estimated end date 2019-07-12 2019-06-21
Actual end date 2019-07-12
Shortage status Resolved Actual shortage
Company comments
Health Canada comments